Is NCT03438461 results overdue?

Yes — results are overdue. Primary completion was 2018-05-30; the FDAAA-801 reporting deadline (2019-05-30) passed 2625 days ago and no results are posted on ClinicalTrials.gov.

A Study to Evaluate the Relative Oral Bioavailability of Seltorexant (JNJ-42847922) After Administration of 3 Different Formulations in Healthy Participants Under Fasted and Semi-fasted Conditions

NCT ID	NCT03438461 ↗
Sponsor	Janssen Research & Development, LLC (INDUSTRY)
Phase	PHASE1
Status	COMPLETED
Primary completion	2018-05-30 (ACTUAL)
Reporting deadline	2019-05-30 (completion + 365d)
Days overdue	2625
Results posted	No — check results tab ↗
FDA-regulated	drug: yes, device: no
Provenance	Flagged overdue on 2026-06-21 · SHA-256 `4e91ce9a91fd4978…` (hash-chained, tamper-evident)

Source of record: ClinicalTrials.gov NCT03438461. The reporting requirement is FDAAA 801 (Public Law 110-85 §801) and the Final Rule, 42 CFR Part 11.